Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |
PMID | |
Authors | Tyler Maclay, Melinda Day, Kevin Mills |
Title | CYT01B, a novel RAD51 inhibitor, acts synergistically with PARP inhibitors |
Journal | AACR Annual Meeting 2019 Online Proceedings |
Vol | |
Issue | |
Date | |
URL | https://www.abstractsonline.com/pp8/#!/6812/presentation/2996 |
Abstract Text | AACR Annual Meeting 2019, Abstract 363 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
Unknown unknown | Advanced Solid Tumor | not applicable | CYT01B + Veliparib | Preclinical - Cell culture | Actionable | In a preclinical study, CYT01B and Veliparib (ABT-888) synergistically inhibited growth of tumor cell lines in culture (AACR Annual Meeting 2019, Abstract 363). | detail... |
Unknown unknown | Advanced Solid Tumor | not applicable | CYT01B + Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, CYT01B and Lynparza (olaparib) synergistically inhibited growth of tumor cell lines in culture (AACR Annual Meeting 2019, Abstract 363). | detail... |
Unknown unknown | Advanced Solid Tumor | not applicable | CYT01B + Rucaparib | Preclinical - Cell culture | Actionable | In a preclinical study, CYT01B and Rubraca (rucaparib) synergistically inhibited growth of tumor cell lines in culture (AACR Annual Meeting 2019, Abstract 363). | detail... |
Unknown unknown | Advanced Solid Tumor | not applicable | CYT01B + Talazoparib | Preclinical - Cell culture | Actionable | In a preclinical study, CYT01B and Talzenna (talazoparib) synergistically inhibited growth of tumor cell lines in culture (AACR Annual Meeting 2019, Abstract 363). | detail... |
Unknown unknown | Advanced Solid Tumor | not applicable | CYT01B + Niraparib | Preclinical - Cell culture | Actionable | In a preclinical study, CYT01B and Zejula (niraparib) synergistically inhibited growth of tumor cell lines in culture (AACR Annual Meeting 2019, Abstract 363). | detail... |